Holen Sie sich die Stockscreener-App
7.52
1.44%
-0.11
Handel nachbörslich:
7.91
0.39
+5.19%
Finanzdaten der Fennec Pharmaceuticals Inc-Aktie (FENC)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
29.11%
12.46
|
9.652 | 8.751 | 7.925 | 6.974 |
Operating Expenses
|
2.16%
12.65
|
12.38 | 9.559 | 8.859 | 12.18 |
| Benefits Costs and Expenses |
-
|
- | 9.916 | 9.545 | - |
| Costs And Expenses |
2.16%
12.65
|
12.38 | 9.916 | 9.545 | 12.18 |
| Operating Income/Loss |
93.08%
-0.189
|
-2.732 | -0.808 | -0.934 | -5.202 |
| Nonoperating Income/Loss |
6.90%
-0.449
|
-0.42 | -0.357 | -0.686 | -0.533 |
| Income/Loss From Continuing Operations Before Tax |
495.37%
12.46
|
-3.152 | -1.165 | -1.62 | 6.974 |
| Income/Loss From Continuing Operations After Tax |
79.76%
-0.638
|
-3.152 | -1.165 | -1.985 | -5.735 |
|
Net Income/Loss
|
79.76%
-0.638
|
-3.152 | -1.165 | -1.985 | -5.735 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.81%
27.89
|
27.66 | 27.58 | -0.077 | 27.37 |
| Diluted Average Shares |
0.81%
27.89
|
27.66 | 27.58 | -0.721 | 27.37 |
| Basic Earnings Per Share |
81.82%
-0.02
|
-0.11 | -0.04 | -0.08 | -0.21 |
| Diluted Earnings Per Share |
81.82%
-0.02
|
-0.11 | -0.04 | -0.08 | -0.21 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):